Method for treating gefitinib resistant cancer | Patent Number 10596162

US 10596162 B2
Application Number15207349
Publication NumberUS 20160310482 A1
Pendency3 years, 8 months, 17 days
Filled DateJul 11, 2016
Priority DateFeb 3, 2005
Publication DateOct 27, 2016
Expiration DateFeb 2, 2025
Inventor/ApplicantsSridhar Krishna Rabindran
Eunice L. Kwak
Daniel A. Haber
Jeffrey E. Settleman
Nadia G. Godin-Heymann
Daphne Winifred Bell
Raffaella Sordella
ExaminesREDDIG, PETER J
Art Unit1642
Technology Center1600
Assignments
Wyeth
Current
WyethMassachusetts General Hospital
Original
Pfizer
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.